BCL6 and aneurysmal bone cyst: Specific markers, including CD10, LM02, and BCL6 are expressed in GCB patients who have a better response to conventional chemotherapy, whereas ABC patients express lower levels of BCL6 and are refractory to chemotherapy [5,7].